Finally, based on the multivariate survival analysis in the whole cohort, our study did not demonstrate a prognostic role of PD-L1, which confirms prior data in locally advanced NSCLC treated with CRT [17,18,19]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.